The year 2020 suddenly saw pharma stocks turn into fund managers’ blue-eyed baby. From a low earnings and valuations base, pharma stocks witnessed large gains from January 2020. As of October 16, 2020, the S&P BSE Healthcare index’s returns increased 48 per cent.
Key to long-term investing: ‘Time in the market’ more important than ‘timing the market’
Read More